Viloxazine Hydrochloride + Sensitive Cyp3a Substrates Interaction
Moderateinteraction on record
Description
Viloxazine significantly increases total exposure of these substrates, which may increase adverse reaction risk. Not recommended for coadministration; dose reduction may be warranted if coadministered.
Mechanism
Strong CYP1A2 inhibition
Source: NLP:viloxazine hydrochloride